ML19239A098
| ML19239A098 | |
| Person / Time | |
|---|---|
| Issue date: | 10/18/2019 |
| From: | Christian Einberg Office of Nuclear Material Safety and Safeguards |
| To: | Metter D Advisory Committee on the Medical Uses of Isotopes |
| Jamerson, Kellee | |
| References | |
| Download: ML19239A098 (2) | |
Text
October 18, 2019 MEMORANDUM TO: Darlene F. Metter, M.D., Chairman Advisory Committee on the Medical Uses of Isotopes FROM: Christian Einberg, Chief /RA/
Medical Safety and Events Assessment Branch Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards
SUBJECT:
U.S. NUCLEAR REGULATORY COMMISSION ACTIONS IN RESPONSE TO THE JULY 24, 2019, TELECONFERENCE MEETING OF THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES Below are the U.S. Nuclear Regulatory Commission (NRC) staffs actions in response to the recommendations from the July 24, 2019, teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI or Committee).
ITEM (1): The Committee agreed that the current medical event abnormal occurrence criteria are not appropriate and need to be reviewed and revised.
The recommendation passed unanimously with 13 votes. The NRC staff will incorporate the Committees recommendation into its notation vote paper to the Commission.
ITEM (2): The Committee endorsed the draft guidance subcommittee report and the recommendations therein.
The recommendation passed unanimously with thirteen votes. The recommendations proposed by the Subcommittee were provided to the NRC staff for consideration for inclusion in the draft guidance document.
CONTACT: Kellee Jamerson, NMSS/MSST (301) 415-7408
ML19239A098 *via email OFFICE MSST/MSEB MSST/MSEB MSST/MSEB NAME KJamerson LDimmick* CEinberg DATE 8/27/2019 8/28/2019 10/11/2019